Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
57,32 USD | -2,23% | +4,69% | +45,32% |
19/03 | Morphic Holding benoemt Simon Cooper als Chief Medical Officer | MT |
15/03 | Aandelen Keros Therapeutics stijgen na FDA Fast Track-aanwijzing voor potentieel geneesmiddel tegen bloedarmoede | MT |
Vakgebied
Aantal werknemers: 136
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jasbir Seehra
CEO | Chief Executive Officer | 68 | 01-12-15 |
Keith Regnante
DFI | Director of Finance/CFO | 54 | 01-02-20 |
Jennifer Lachey
CTO | Chief Tech/Sci/R&D Officer | 51 | 01-07-16 |
Chief Operating Officer | 50 | 01-02-22 | |
Justin Frantz
IRC | Investor Relations Contact | - | - |
Robin Wagner
HRO | Human Resources Officer | - | 01-06-21 |
Esther Cho
LAW | General Counsel | - | 01-04-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 17-12-20 |
Carl Gordon
CHM | Chairman | 59 | 01-03-20 |
Jasbir Seehra
CEO | Chief Executive Officer | 68 | 01-12-15 |
Tomer Kariv
BRD | Director/Board Member | 62 | 01-01-20 |
Ran Nussbaum
BRD | Director/Board Member | 51 | 01-04-16 |
Nima Farzan
BRD | Director/Board Member | 48 | 01-03-20 |
Julius Knowles
BRD | Director/Board Member | 61 | 01-04-16 |
Alpna Seth
BRD | Director/Board Member | 60 | 01-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 36 067 786 | 33 773 264 ( 93,64 %) | 0 | 93,64 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+45,32% | 2,11 mld. | |
-3,13% | 102 mld. | |
+1,48% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,66% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,67% | 16,36 mld. | |
+4,97% | 13,97 mld. | |
+32,56% | 12,17 mld. |
- Beurs
- Aandelen
- Koers KROS
- Onderneming Keros Therapeutics, Inc.